Stay updated on Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the previous v3.5.3, indicating an updated page build without changes to displayed content.
    Difference
    0.0%
    Check dated 2026-05-17T10:14:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The study record dates have been updated to include new entries (2026-05-01, 2027-02-25, 2026-04-17, 2026-04) and remove earlier entries (2025-05-07, 2026-03-25, 2025-04-29, 2025-04), reflecting adjustments to the posting and QC timeline on the page.
    Difference
    0.2%
    Check dated 2026-05-03T01:20:23.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page version/build indicator was updated from v3.5.2 to v3.5.3, reflecting a minor administrative release rather than a substantive change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:53.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:33:58.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    - Updated page revision from v3.4.3 to v3.5.0. This appears to be an administrative update and does not modify study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-21T01:21:18.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 as part of a site update. This change does not modify study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:48:10.000Z thumbnail image

Stay in the know with updates to Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.